Next Patent: Dry cleansing wipe with improved rinsibility
Next Patent: Dry cleansing wipe with improved rinsibility
[0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 60/339,386 entitled PRODUCT and filed on Dec. 13, 2001, the entire content of which is hereby incorporated by reference.
[0002] 1. Field of the Invention
[0003] The present invention relates to hygiene tissues to be used to establish and maintain a beneficial microbial flora on the skin and the urogenital area in combination with cleaning and caring of these areas.
[0004] 2. Background of the Invention
[0005] The urogenital area harbors a complex microbial ecosystem comprising more than 50 different bacterial species (Hill et al., Scand. J. Urol. Nephrol. 1984;86 (suppl.) 23-29). The dominating species in this area are lactic acid producing bacteria belonging to the genus Lactobacillus. These lactic acid producing members are important for retaining a healthy microbial flora in these areas, and act as probiotic bacteria with an antagonistic effect against pathogenic microbial species. Lactic acid producing bacteria inhibit growth and colonization by other microorganisms by occupying suitable niches for colonization, by forming biofilms, and competing for available nutrients, thereby excluding colonization by harmful microorganisms. Also, the production of enzymes, such as hydrogen peroxidase, and specific inhibiting substances, such as toxins and bacteriocines, and organic acids (including lactic acid and acetic acid) that lower the pH, inhibit colonization by other microorganisms. However, the microbial ecosystem of a healthy individual can be disturbed by the use of antibiotics, in people suffering from diabetes, during hormonal changes, such as during pregnancy or use of contraceptives with estrogen, during menstruation, after menopause, etc. Also, microorganisms can spread from the anus to the urogenital area, thereby causing infections. This results in a disturbance of the normal microbial flora and leaves the individual susceptible to microbial infections that cause vaginitis, urinary tract infections and ordinary skin infections. Microorganisms commonly associated with these kind of infections belong to the genera Escherichia, Enterococcus, Psedomonas, Proteus, Klebsiella, Streptococcus, Staphylococcus, Gardnerella and Candida. Women are at particular risk due to their shorter distance between the anus and the urogenital tract; specially at risk are young women, who not yet have a well developed microflora in the urogenital area and older women, who no longer have a protective flora.
[0006] Similarly to the urogenital area, the skin is colonized by an array of organisms, which forms its normal flora. The numbers and identity of the organisms vary between different skin sites. This, together with the skin's structural barrier, provides the host with an excellent defense against invading microbes. The number of bacteria on the skin vary from a few hundred per cm
[0007]
[0008] Other common skin infections are caused by
[0009]
[0010] Malassezia (formerly Pityrosporum) are probably universal inhabitants of the head and thorax in adult humans. Species of this organism are known to be involved in the skin diseases seborrhoeic dermatitis and pityriasis versicolor and to play a part in the aetiology of severe dandruff. These yeasts may also play a part in exacerbation of atopic dermatitis.
[0011] So called ringworm infections of the skin may be caused by dermatophyte fungi, e.g., Tricophyton, Epidermophyton and Microsporum.
[0012] The relative dryness of most areas of skin limits the growth of Candida, which therefore are found in low numbers on healthy skin. However Candida rapidly colonizes damaged skin and intertriginous sites (apposed skin sites which are moist and become chafed). Candida also colonizes the oral and vaginal mucosa and overgrowth may result in disease in these sites (so called thrush).
[0013] One way to reduce the problems with the kind of infections described above is to have a good personal hygiene. However, excessive use of cleaning agents not only decrease the amount of harmful microbes, but can harm the beneficial microbial flora, again render it susceptible for pathogenic species to colonize and cause infections. Alternatively, administration of lactic acid producing bacteria to the urogenital area and the skin in order to out compete pathogenic species and facilitating establishment and maintenance of a beneficial microbial flora in these areas, have been found to be a successful means to treat and prevent microbial infections.
[0014] It has been suggested that lactic acid producing bacteria can be delivered via absorbent articles, such as diapers, sanitary napkins, panty liners and tampons, as described in, for example, in WO97/02846, WO99/17813, WO99/45099 and WO00/35502. However, absorbent articles may not always be an optimal administration route, since carrying of an absorbent article often is apprehended as uncomfortable, indiscrete and warm. This administration route can also be inconvenient as repeated administration of lactic acid producing bacteria often is necessary to retain the efficacy of the treatment or the preventative effect. Also, these products are not generally used for delivery of the bacteria to other regions of the body than the urogenital area. Therefore, for some applications it can be more convenient to administer lactic acid producing bacteria by other means than absorbent products. A second problem with administration of lactic acid producing bacteria via absorbent articles relates to the manufacturing of such products, since a wide selection of variants and sizes of the product have to be supplied with the bacteria. Therefore the administration via a product that could be used without individual adjustments could provide a manufacturing advantage over the absorbent products.
[0015] However, a problem with providing articles intended to be used for transfer of lactic acid producing bacteria, is that the bacteria have to retain viability during transport and storage of the articles. Lactic acid producing bacteria rapidly lose viability under moist conditions, and it is therefore important that the products are not exposed to moisture-. One way to partly overcome this problem has been to supply articles with freeze-dried lactic acid producing bacteria, thereby providing long shelf-life products containing viable lactic acid producing bacteria. However, the bacteria still have to be protected against moisture during the time between manufacturing and use.
[0016] Alternatively, research experiments have shown that storage in sterile vaseline oil results in a high level of viable lactobacilli cells after
[0017] There is still a need to develop products for delivery of lactic acid producing bacteria to the skin and urogenital area that are convenient to use, result in efficient transfer of the bacteria to the area where they are applied and can be stored for long time periods without loss of viability of the bacterial cells.
[0018] An object of the present invention is to provide a convenient device for the delivery of lactic acid producing bacteria to the skin and urogenital area. This is obtained by providing a hygiene tissue, comprising viable lactic acid producing bacteria, that can be used for cleaning and caring the skin while simultaneously delivering the lactic acid producing bacteria, to establish and maintain a beneficial microflora on the skin and the urogenital area. In order to provide products that can be stored for long time periods, without loss of viability of the lactic acid producing bacteria, the bacterial cells are suspended in a lipid that protects the bacteria from moisture. Also an object of the present invention is to provide moisture impervious packing units comprising the hygiene tissue of the invention.
[0019] One preferred embodiment of the present invention pertains to a hygiene tissue to be used for cleaning and caring of the skin and the urogenital area simultaneously as it delivers lactic acid producing bacteria, thereby establishing and maintaining a healthy microbial flora in these areas. The hygiene tissue is impregnated with a composition comprising a lactic acid producing bacterium/bacteria suspended in a lipid and optionally additional components. The present inventors surprisingly found that encapsulating the lactic acid bacterium in a lipid provided a moisturefree environment keeping the bacterium in a shape that resulted in enhanced longevity, high transfer rates to the skin, and still keeping fitness for survival and growth on the skin. Therefore, by this approach, bacterial survival was enhanced during long term storage. Also, the hygiene tissue of the preferred embodiment improved the efficiency of transfer of the lactic acid producing bacterium to the skin and urogenital area, simultaneously as the lipid served as a cleaning agent with skin caring properties. Furthermore, the embodiment relates to an impervious packing unit comprising the hygiene tissue described above.
[0020] The objects and advantages of the invention will become apparent from the following detailed description of preferred embodiments thereof in connection with the accompanying drawings in which like numerals designate like elements and in which:
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040] By “hygiene tissue” is meant any device for wiping skin, for instance, a washcloth, patch, towelette, napkin, wetwipe, and the like.
[0041] By “matrix” is meant any natural or synthetic fiber, such as felt, batting, rayon, cellulose, regenerated cellulose, polyester, polyolefin fibers, textile and the like, or foam, or combinations thereof.
[0042] Preferred “lactic acid producing bacterium” include bacteria from the genera Lactobacillus, Lactococcus and Pediococcus. Preferably the selected bacterium used is from the species
[0043] By “lipid” is meant a water-insoluble organic molecule with a fatty character. Suitable lipids for the present invention include petroleum-derived lipids, synthetic lipids, and animal- and plant-derived lipids.
[0044] By “additional component” is meant agents commonly added to skin caring products, such as caring agents, water absorbent agents, pH buffering agents (weak organic or inorganic acids, such as lactic acid, ascorbic acid, citric acid or boric acid), perfume, antioxidants, hydrocortisone, other anti-inflammatory steroids, etc. Further details on suitable agents commonly added to skin caring products are given in Harry's Cosmeticology 8th ed., Ed by M M Rieger, Chemical Publishing Co., Inc., New York, 2000.
[0045] By “moisture impervious packing unit” is meant a packing unit having a highest water vapor transmission rate of 6 g/m
[0046] The hygiene tissue can be used for cleaning and simultaneously establishing and maintaining a healthy microbial flora on the skin and in the urogenital area. The hygiene tissue provided can be composed of a matrix comprising any natural or synthetic fiber, such as felt, batting, rayon, cellulose, regenerated cellulose, polyester, polyolefin fibers, textile and the like, or foam, or combinations thereof. The water content of the matrix of the hygiene tissue is preferably 10% or less (by weight), more preferably 5% or less (by weight), and most preferably 1% or less (by weight). The hygiene tissue is impregnated with a suspension of a lactic acid producing bacterium in a lipid. The lipid encapsulates the bacteria and thereby acts to protect the bacteria from moisture, which enhances bacterial survival during manufacturing and storage. Preferably the the lactic acid producing bacteria are present directly in the lipid phase, but the bacteria can also be present in microincapsulated forms. Exposure to moisture during manufacturing and storage of products that comprise lactic acid producing bacteria, causes reactivation of the bacteria, which subsequently leads to their death. Therefore, by protecting the bacteria from moisture, their survival is enhanced and the durability of the product extended. The inventors also found that encapsulating the bacteria in lipid resulted in enhanced transfer rates to and survival of the bacteria on the skin after their delivery to it (see Example 3 below). This can be an effect of the lipid creating a micromilieu, that is beneficial for retaining bacterial viability and that enhances growth of the added bacteria on the skin. Also, the lipid has more adhesive properties than, for example, water, thereby resulting in a higher amount of bacteria actually being transferred to the skin. In addition to its bacterial survival enhancing properties, the lipid also serves as a skin treatment agent that cleans the skin without causing drying out. Once the bacteria have been delivered to the skin, the moisture on the skin reactivates the bacteria, thereby allowing them to perform their intended action, i.e., competitively exclude and minimize colonization of pathogenic microbial species. Optionally, additional substances, including water absorbent agents (such as inorganic salts, e.g., calcium chloride), tensides (non-ionic, amphoteric and anionic surfactants), pH buffering agents (weak organic or inorganic acids, such as lactic acid, ascorbic acid, citric acid or boric acid), perfume, antioxidants, hydrocortisone and other anti-inflammatory steroids, can also be added to the lipid-bacterial suspension, or directly to the hygiene tissue.
[0047] The amount of lipid suspension of lactic acid producing bacteria on the tissue is preferably 0.5-95% by weight.
[0048] The number of probiotic bacteria on the hygiene tissue is preferably 10
[0049] In one preferred embodiment the probiotic bacterial strain with antagonistic effect is selected from the genera Pediococcus, Lactobacillus or Lactococcus including combinations thereof. The lactic acid producing bacterial strain is preferably isolated from the skin or urogenital area of a healthy person.
[0050] In another preferred embodiment the probiotic bacterial strain with antagonistic effect is at least a
[0051] In an even more preferred embodiment the probiotic bacterial strain with antagonistic effect is at least
[0052] Preferable lipids for the present invention support survival of the stored cells so that the maximum decrease in number of culturable cells is 3 log units after 12 months storage. Preferable lipids have a water content of 5% or less (by weight), preferably 3% or less (by weight), most preferably 1% or less (by weight). More preferably, suitable lipids support survival of the stored cells so that the maximum decrease in number of culturable cells is 2 log units after 12 months storage. Most preferably, suitable lipids support survival of the stored cells so that the maximum decrease in number of culturable cells is 1 log unit after 12 months storage.
[0053] Preferable lipids enable transfer of bacteria to the skin of 10
[0054] Preferable lipids are also characterized by supporting survival of the bacterial cells on the skin so that 10
[0055] Preferable lipids for the present invention include petroleum-derived lipids, such as paraffinum liquidum (mineral oils, paraffin oils, and vaseline oils), petrolatum (vaseline and petroleum jelly), cera microcrystallina, ozokerite, ceresine and paraffins. Alternatively, synthetic lipids, such as Dimethicone, Cyclomethicone and silicone esters, such as cetearyl methicone can be used. A third alternative is to use animal- or plant-derived lipids, which usually are triglycerides. The naturally animal- or plant-derived lipids are often mixtures of mono-, di- and triglycerides and free fatty acids. The lipids may be purified, hydrogenated, refined, modified and used alone or in different mixtures. Examples of suitable, original animal-derived lipids include bees' waxes, emu oil, lactis lipida, lanolin, shark liver oil and tallow. Examples of suitable plant-derived original lipids include apricot kernel oil, arachis oil, avocado oil/wax, bayberry wax, black currant seed oil, borage seed oil, brazil nut oil, camelia sinensis oil, candelilla wax, canola oil, carnauba wax, castor oil, cocoa butter, coconut oil, corn oil, cotton seed oil, dog rose seed oil, evening primrose seed oil, grape seed oil, illipe butter, jasmine wax, jojoba wax, lavender wax, linseed oil, mango seed oil, olive oil, orange wax, palm oil, palm kernel oil, peanut oil, rice wax, safflower oil, sesame seed oil, shea butter, soybean oil, sunflower seed wax, sweet almond oil and wheat germ oil. The lipids can be used alone or in mixtures comprising at least two lipids.
[0056] Preferably, a liquid lipid is used in the present invention. More preferred lipids include olive oil, canola oil, coconut oil, palm kernel oil, peanut oil, soy bean oil, Dimethicone, paraffin oil, and petrolatum. These lipids are especially preferred because they provide high survival of lactic acid bacteria and high transfer rates of the bacteria to the skin and urogenital area. In addition, these lipids have positive effects on the skin; they have a soothing effect, show skin-protective properties, and are non-toxic and non-allergenic. The preferred lipids are all of non-animal origin.
[0057] In order to protect the probiotic bacteria from moisture during storage and transportation, the hygiene tissue is preferably provided individually packed in a moisture impervious packing unit. The packing unit can be constructed in several different ways. The material used preferably should not have a vapor permeability exceeding 6 g/m
[0058] A preparation of freeze dried
[0059] As a comparison to storage of
[0060] To test the viability of the
[0061] The survival of
[0062] 497 mg of a powder of
[0063] In addition to the experiment described above, to further compare the survival of
[0064] As a comparison to storage of
[0065]
[0066] 2.00 g of freeze-dried
[0067] As shown in FIGS.
[0068] A bacterial suspension was prepared by adding 5.051 g of a powder of
[0069] The girls were not allowed to take a bath or shower during the study, but were not given instructions in any other respect. The results shown in
[0070] Growth of
[0071]
[0072] LB931 and ATCC were grown on MRS agar plates for two days at 37° C. in CO
[0073] The suspension was centrifuged for 20 minutes at 3000×g at 4° C., and the pellet was washed three times in 10-20 ml NaCl (0.9%). After washing, the pellet was resuspended in 2.5 ml NaCl (0.9%)+2.5 ml skim milk, thereby concentrating the sample 10×. This suspension was transferred to an actuator vial. Each 10+1 (test) panty liners were sprayed with about 150 mg of bacterial suspension. The panty liners were dried for 6 hours at room temperature before being packaged one by one into mini-grip bags.
[0074] Control of colony forming units (CFU) of the test panty liner: 50 ml of NaCl (0.9%) was poured over the panty liner in a stomacher bag and run at high speed for 3 minutes. The fluid is diluted and 100 μl was spread on MRS agar plates. The number of CFU/panty liner for ATCC 8014 was 3×10
[0075] Women took a time zero sample (perineum and urethra) before wearing a panty liner supplied with either of the
[0076] As shown in
[0077] A similar difference was observed when the number of bacteria that still were present in the urethra was determined 24 hours after the time zero sample was taken. In this case, 62% of the women who had used panty liners with LB931 harbored the bacteria (
[0078] LB931 and ATCC 9014 were grown as described above, but to a final volume of 100 ml each. The suspension was centrifuged and resuspended in 10 ml of PBS, in a Falcon tube (size 50 ml). The tube was incubated at 37° C. for 5 hours. Thereafter the suspension was centrifuged and the supernatant (PBS sup) collected, containing inhibiting substances secreted by the lactic acid bacteria. The PBS sup was stored at −20° C. until use. For controls, PBS buffer, pH adjusted (pH 5.1) and unadjusted (pH 7.3) were used.
[0079] The ability of the two tested
[0080] As can be seen in FIGS.
[0081] It is apparent from Examples 6 and 7 that the ability of LB931 to be transferred and maintained in the urogenital area is higher than it is for another
[0082] Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without department from the spirit and scope of the invention as defined in the appended claims.